278 related articles for article (PubMed ID: 38264091)
1. The efficacy and safety of third-generation antiseizure medications and non-invasive brain stimulation to treat refractory epilepsy: a systematic review and network meta-analysis study.
Yang Y; Shangguan Y; Wang X; Liu R; Shen Z; Tang M; Jiang G
Front Neurol; 2023; 14():1307296. PubMed ID: 38264091
[TBL] [Abstract][Full Text] [Related]
2. Third-Generation Antiseizure Medications for Adjunctive Treatment of Focal-Onset Seizures in Adults: A Systematic Review and Network Meta-analysis.
Lattanzi S; Trinka E; Zaccara G; Striano P; Russo E; Del Giovane C; Silvestrini M; Brigo F
Drugs; 2022 Feb; 82(2):199-218. PubMed ID: 35061214
[TBL] [Abstract][Full Text] [Related]
3. Efficacy, tolerability and safety of add-on third-generation antiseizure medications in treating focal seizures worldwide: a network meta-analysis of randomised, placebo-controlled trials.
Chen Y; Li W; Lu C; Gao X; Song H; Zhang Y; Zhao S; Cai G; Guo Q; Zhou D; Chen Y
EClinicalMedicine; 2024 Apr; 70():102513. PubMed ID: 38449838
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Safety of Five Broad-Spectrum Antiseizure Medications for Adjunctive Treatment of Refractory Epilepsy: A Systematic Review and Network Meta-analysis.
Wang H; Wang H; Liu Y; Zhao J; Niu X; Zhu L; Ma X; Zong Y; Huang Y; Zhang W; Han Y
CNS Drugs; 2023 Oct; 37(10):883-913. PubMed ID: 37589821
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and Tolerability of Adjunctive Brivaracetam in Patients with Focal-Onset Seizures on Specific Concomitant Antiseizure Medications: Pooled Analysis of Double-Blind, Placebo-Controlled Trials.
Moseley B; Bourikas D; Dimova S; Elmoufti S; Borghs S
Adv Ther; 2024 Apr; 41(4):1746-1758. PubMed ID: 38356105
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of add-on antiseizure medications for focal epilepsy: A network meta-analysis.
Zhang H; Ou Z; Zhang E; Liu W; Hao N; Chen Y; Liu Y; Ye H; Zhou D; Wu X
Epilepsia Open; 2024 Jun; ():. PubMed ID: 38888005
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of brivaracetam compared to lacosamide, eslicarbazepine acetate, and perampanel as adjunctive treatments in uncontrolled focal epilepsy: Results of an indirect comparison meta-analysis of RCTs.
Brigo F; Bragazzi NL; Nardone R; Trinka E
Seizure; 2016 Nov; 42():29-37. PubMed ID: 27710868
[TBL] [Abstract][Full Text] [Related]
8. Retention, efficacy, tolerability, and quality of life during long-term adjunctive brivaracetam treatment by number of lifetime antiseizure medications: A post hoc analysis of phase 3 trials in adults with focal seizures.
Brandt C; Dimova S; Elmoufti S; Laloyaux C; Nondonfaz X; Klein P
Epilepsy Behav; 2023 Jan; 138():108967. PubMed ID: 36435010
[TBL] [Abstract][Full Text] [Related]
9. Effect of Number of Previous Antiseizure Medications on Efficacy and Tolerability of Adjunctive Brivaracetam for Uncontrolled Focal Seizures: Post Hoc Analysis.
Lee SK; Heo K; Kim SE; Lee SA; Elmoufti S; Laloyaux C; Hur B
Adv Ther; 2021 Jul; 38(7):4082-4099. PubMed ID: 34155568
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of adjunctive cenobamate based on number of concomitant antiseizure medications, seizure frequency, and epilepsy duration at baseline: A post-hoc analysis of a randomized clinical study.
Rosenfeld WE; Nisman A; Ferrari L
Epilepsy Res; 2021 May; 172():106592. PubMed ID: 33662894
[TBL] [Abstract][Full Text] [Related]
11. A real-world comparison among third-generation antiseizure medications: Results from the COMPARE study.
Roberti R; Di Gennaro G; Anzellotti F; Arnaldi D; Belcastro V; Beretta S; Boero G; Bonanni P; Canafoglia L; D'Aniello A; Dainese F; De Caro C; Di Gennaro G; Di Giacomo R; DiFrancesco JC; Dono F; Falcicchio G; Ferlazzo E; Foschi N; Franciotta S; Gambardella A; Giordano A; Iannone LF; Labate A; La Neve A; Lattanzi S; Leggio U; Liguori C; Maschio M; Nilo A; Operto FF; Pascarella A; Pauletto G; Renna R; Strigaro G; ; Russo E
Epilepsia; 2024 Feb; 65(2):456-472. PubMed ID: 38052481
[TBL] [Abstract][Full Text] [Related]
12. Tolerability and efficacy of adjunctive brivaracetam in adults with focal seizures by concomitant antiseizure medication use: Pooled results from three phase 3 trials.
Ryvlin P; Dimova S; Elmoufti S; Floricel F; Laloyaux C; Nondonfaz X; Biton V
Epilepsia; 2022 Aug; 63(8):2024-2036. PubMed ID: 35582748
[TBL] [Abstract][Full Text] [Related]
13. Indirect treatment comparison of cenobamate to other ASMs for the treatment of uncontrolled focal seizures.
Privitera M; Richy FF; Schabert VF
Epilepsy Behav; 2022 Jan; 126():108429. PubMed ID: 34864380
[TBL] [Abstract][Full Text] [Related]
14. Transcranial magnetic stimulation for the treatment of epilepsy.
Walton D; Spencer DC; Nevitt SJ; Michael BD
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD011025. PubMed ID: 33884611
[TBL] [Abstract][Full Text] [Related]
15. Number needed to treat and associated cost analysis of cenobamate versus third-generation anti-seizure medications for the treatment of focal-onset seizures in patients with drug-resistant epilepsy in Spain.
Villanueva V; Serratosa JM; Toledo M; Ángel Calleja M; Navarro A; Sabaniego J; Pérez-Domper P; Álvarez-Barón E; Subías S; Gil A
Epilepsy Behav; 2023 Feb; 139():109054. PubMed ID: 36603345
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of six new antiseizure medications for adjunctive treatment of focal epilepsy and epileptic syndrome: A systematic review and network meta-analysis.
Tong J; Ji T; Liu T; Liu J; Chen Y; Li Z; Lu N; Li Q
Epilepsy Behav; 2024 Mar; 152():109653. PubMed ID: 38277848
[TBL] [Abstract][Full Text] [Related]
17. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
18. A comparison of cenobamate with other newer antiseizure medications for adjunctive treatment of focal-onset seizures: A systematic review and network meta-analysis.
Mulheron S; Leahy TP; McStravick M; Doran R; Delanty N
Seizure; 2024 May; 118():80-90. PubMed ID: 38643679
[TBL] [Abstract][Full Text] [Related]
19. Third-Generation Antiseizure Medication in the Treatment of Benzodiazepine-Refractory Status Epilepticus in Poststroke Epilepsy: A Retrospective Observational Register-Based Study.
Winter Y; Sandner K; Vieth T; Gonzalez-Escamilla G; Stuckrad-Barre SV; Groppa S
CNS Drugs; 2023 Oct; 37(10):929-936. PubMed ID: 37784006
[TBL] [Abstract][Full Text] [Related]
20. Suicidality Risk of Newer Antiseizure Medications: A Meta-analysis.
Klein P; Devinsky O; French J; Harden C; Krauss GL; McCarter R; Sperling MR
JAMA Neurol; 2021 Sep; 78(9):1118-1127. PubMed ID: 34338718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
